• HALOBETASOL PROPIONATE CHEMBL1200908 FDA Approved

    Alternate Names:

    Ulobetasol
    Halobetasol Propionate
    BMY-30056
    Ultravate
    CGP-14458
    Ultravate X
    Ultravate Pac-cream
    Ultravate Pac
    Ultravate Ointment 0.05%
    Ultravate Cream
    Hobs
    Halovate
    Halobetasol
    98651-66-2
    21-chloro diflorasone
    DB00596
    (1R,8S,13S,14R)-14-(2-CHLOROACETYL)-1,8-DIFLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0?,?.0??,??]HEPTADECA-3,6-DIEN-14-YL PROPANOATE
    (1R,8S,13S,14R)-14-(2-CHLOROACETYL)-1,8-DIFLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PROPANOATE
    3B2-1279
    PL066286
    K097
    DR002999
    AN-14228
    CID6918178
    DAP001186
    [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-CHLOROACETYL)-6,9-DIFLUORO-11-HYDROXY-10,13,16-TRIMETHYL-3-OXO-6,7,8,11,12,14,15,16-OCTAHYDROCYCLOPENTA[A]PHENANTHREN-17-YL] PROPANOATE
    CHEMBL1876307
    SCHEMBL1650038
    D04409
    CID48175
    ULOBETASOLUM
    AC1OCF43
    PREGNA-1,4-DIENE-3,20-DIONE, 21-CHLORO-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)-,(6-ALPHA,11-BETA,16-BETA)-
    PREGNA-1,4-DIENE-3,20-DIONE, 21-CHLORO-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)-, (6ALPHA,11BETA,16BETA)-
    21-CHLORO-6ALPHA,9-DIFLUORO-11BETA,17-DIHYDROXY-16BETA-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-PROPIONATE
    ULTRAVATE (TN)
    HALOBETASOL PROPIONATE (USAN)
    [(6S,9R,16S,17R)-17-(2-CHLOROACETYL)-6,9-DIFLUORO-11-HYDROXY-10,13,16-TRIMETHYL-3-OXO-6,7,8,11,12,14,15,16-OCTAHYDROCYCLOPENTA[A]PHENANTHREN-17-YL] PROPANOATE
    LS-118431
    NCGC00167451-01
    6 ALPHA-FLUOROCLOBETASOL 17-PROPIONATE
    BMY 30056
    6-FLUOROCLOBETASOL 17-PROPIONATE
    HALOBETASOL PROPIONATE [USAN]
    MIRACORTEN
    AC1L2JJ6
    C25H31CLF2O5
    ULOBETASOL CREAM
    48175
    (6|A,11|A,16|A)-21-CHLORO-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)PREGNA-1,4-DIENE-3,20-DIONE; MIRACORTEN; ULOBETASOL PROPIONATE; ULTRAVATE
    (6|A,11|A,16|A)-21-CHLORO-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)PREGNA-1,4-DIENE-3,20-DIONE
    S4089,66852-54-8
    FT-0630768
    CAS-66852-54-8
    AB2000750
    AKOS025310143
    TOX21_112455
    ZINC3920028
    HY-B0878
    HALOBETASOL PROPIONATE [USAN:USP]
    MOLPORT-023-278-129
    BDSYKGHYMJNPAB-LICBFIPMSA-N
    CTK8G0126
    SCHEMBL33858
    DSSTOX_GSID_46636
    DSSTOX_RID_81782
    DSSTOX_CID_26636
    HALOBETASOL (PROPIONATE)
    HALOBETASOLPROPIONATE
    91A0K1TY3Z
    UNII-91A0K1TY3Z
    66852-54-8
    ULOBETASOL PROPIONATE
    6918178
    187307

    Drug Info:

    FDA Approval 1990
    Drug Class small molecule
    Drug Indications Anti-inflammatory Agents
    Drug Type small molecule
    Drug Categories vasoconstrictor agents
    Drug Categories therapeutic uses
    Drug Categories steroids, fluorinated
    Drug Categories steroids
    Drug Categories psoriasis
    Drug Categories pregnanes
    Drug Categories pregnadienetriols
    Drug Categories pregnadienes
    Drug Categories polycyclic compounds
    Drug Categories pharmacologic actions
    Drug Categories dermatologicals
    Drug Categories dermatologic agents
    Drug Categories corticosteroids, potent (group iii)
    Drug Categories corticosteroids, plain
    Drug Categories corticosteroids, dermatological preparations
    Drug Categories chemical actions and uses
    Drug Categories cardiovascular agents
    Drug Categories betamethasone
    Drug Groups approved
    Drug Class anti-inflammatory agents
    Year of Approval 1990
    (3 More Sources)